It is tempting to speculate that FOXL2 mutated tumor cells continue to proliferate slowly, so relapse may ensue if all residual tumor cells are not removed by surgery or if systemic immunoediting cannot control the tumor growth. This evidence concerns the gene FOXL2 and neoplasm.